Supplementary Materials and Methods

Discovery proteomics of neural progenitor cells (NPCs).
NPCs were cultivated in three biological batches using the standardized protocol described below. NPCs were first grown to confluence in an undifferentiated state (approximately 10-15x10 6 cells/T-175). At t = 0, NPCs were seeded in a fresh T-175 at a density of 50,000 cells/cm 2 (approximately 8.7x10 6 cells) and grown in differentiation medium (depleted of FGF and EGF) for the indicated times. The control t = 0 culture was also transferred to a fresh T-175 but was cultivated in presence of growth factors for an additional 24 h before collection. Thus, for each biological replicate, each time point (t = 0, 1, 2, 4, 7, 14, 21 and 28 days) represented a separate cell culture (in a separate T-175 dish) sharing the same biological origin.
At each time point, cells were collected from a given T-175 dish, rinsed with PBS, pelleted at low speed and stored at -80°C until processed.
NPCs collected from one T-175 dish (approximately 10-20x10 6 cells) were lysed by sonication in 1 ml of 40 mM Tris and 600 mM NaCl, pH 8.8, supplemented with Protease inhibitor complete (Roche) and 3 l of Benzonase (Sigma). The lysates were then subjected to ultracentrifugation at 100,000 g for 1 h at 10°C. The insoluble membrane fraction was then washed twice with 1 M KCl and then twice with 0.1 M Na 2 CO 3 (each wash followed by a 1 h centrifugation step at 50,000 g at 4°C) to remove the bulk of the contaminating soluble proteins. The crude membrane protein fraction was then solubilized in 8 M urea, 1% (w/v) CHAPS and 50 mM Tris/HCl, pH 8.8, and the total protein concentration was estimated using the Bradford assay (BioRad). After proteins were reduced and alkylated with DTE and iodoacetamide, respectively, 10 g of total protein was applied onto two duplicate 4-12% Bis-Tris NuPAGE gels (MES buffer system, Novex), with each gel encompassing one complete biological experiment (one time point per lane). In addition, for each biological experiment, 10 g of a sample consisting of an equivalent amount of protein pooled from each time point was also analyzed separately on a separate SDS-PAGE gel (2 lanes/biological replicate). After the proteins were stained with Colloidal Blue (Novex), each lane was then gridded into 12 bands each (using the molecular mass markers as a reference) that were subsequently subjected to in-gel digestion as described below. Each sample was destained with 50 mM ammonium bicarbonate and 30% (v/v) acetonitrile and then briefly dried in a Speed-Vac concentrator before being re-suspended in 20 l of 50 mM ammonium bicarbonate containing 10 ng trypsin (Promega) overnight at room temperature. Peptides were successively extracted using 100 l of acetonitrile, 100 l of 1% (v/v) formic acid and 100 l of acetonitrile, and the three fractions were pooled and dried using a Speed- 
Glypican-2 interaction profiling by immunocompetitive capture mass spectrometry
Immunocompetitive capture mass spectrometry was performed essentially as previously described (1). Briefly, 21-day differentiated NPCs were harvested and lysed in Dulbecco's phosphate-buffered saline containing CaCl 2 , MgCl 2 (Gibco), 1% NP40 (Calbiochem) and protease inhibitor, complete, EDTA-free (Roche). After a 15-min incubation on ice, lysates were cleared by centrifugation at 14,000 rpm for 10 min at 4°C, and protein concentrations were estimated using the bicinchoninic acid protein assay kit (Pierce). In-house produced anti-GPC2 or anti-FGF2 antibodies (Abcam ab126861) were coupled to Affi-Gel 10 agarose beads (Bio-Rad) for 3 h at 4°C. Unreacted binding sites were blocked by the addition of 0.2 M ethanolamine, and the beads were washed four times with cold PBS and stored at 4°C.
Beads (20 l) were incubated with cell lysates (850 µg total protein per condition)
for 1 h at 4°C, washed four times with lysis buffer and eluted with SDS sample buffer.
For the competition experiments, cell lysates were pre-incubated with increasing amounts of free anti-GPC2 antibody (0, 100, 250, 500 and 1,000 ng) in triplicate for 1 h before incubation with the immobilized anti-GPC2 antibody. Eluates were separated on a 4-20% Tris-Glycine SDS-PAGE gel, and proteins were stained with Colloidal Blue (Novex). Four bands ranging from 20 to 120 kDa were excised and subjected to in-gel digestion with trypsin using standard procedures.
Samples were analyzed with a nanoflow Easy-nLC system (Proxeon) connected to an LTQ-Orbitrap Velos (Thermo Fischer Scientific). Peptides were loaded onto an AQUA C18 trap (100 m x 10 mm, Phenomenex) and separated on a ReproSilPurC18-AQ (75 m x 200 mm, 3 m particle size, 120 Å, Dr. Maisch GmbH)
analytical column using a 50-min gradient of 0-35% acetonitrile (with 0.6% acetic acid) at a rate of 250 nL/min. Full-scan MS spectra were acquired in the Orbitrap with a resolution of r = 60,000 (at m/z 400). The detected ions were recalibrated on the fly entries, including splice variants) using Sequest (version 27.0, revision 12, both Thermo Fisher Scientific). Only fully trypsinized peptides with no more than one missed cleavage were considered, and mass tolerances of 5 ppm and 10 ppm were used for the precursor and fragment ions, respectively. Oxidized methionine (+15.9949 Da) was set as a differential modification, and carbamidomethylated cysteines (+57.0215 Da) were set as a static modification. The spectral false discovery rate (specFDR) was restricted to 1.0% by performing a target-decoy search using a concatenated-decoy database.
The top ranked GPC2-interacting protein candidates FGF2, ECHA and ECHB were confirmed by Western blotting. The proteins were detected with Abcam anti-ECHA (ab54477), anti-ECHB (ab88256) and anti-FGF2 (ab126861) antibodies; the latter was also used for the co-immunoprecipitation experiment.
